Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,66 USD | -3,08% | -8,27% | +26,91% |
Omzet 2024 * | 66,29 mln. 61,56 mln. | Omzet 2025 * | 78,82 mln. 73,18 mln. | Marktkapitalisatie | 877 mln. 814 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -163 mln. -151 mln. | Nettowinst (verlies) 2025 * | -124 mln. -115 mln. | EV/omzet 2024 * | 13,2 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 11,1 x |
K/w-verhouding 2024 * |
-4,86
x | K/w-verhouding 2025 * |
-6,78
x | Werknemers | 267 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,97% |
Recentste transcriptie over Ocular Therapeutix, Inc.
1 dag | -3,08% | ||
1 week | -8,27% | ||
Lopende maand | +19,41% | ||
1 maand | -28,45% | ||
3 maanden | -0,35% | ||
6 maanden | +168,88% | ||
Lopend jaar | +26,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 25-09-17 |
Chief Tech/Sci/R&D Officer | - | 28-09-21 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 08-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 10-07-23 |
Director/Board Member | 76 | 05-11-12 | |
Merilee Raines
BRD | Director/Board Member | 68 | 20-09-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 0 M€ | +9,18% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 5,66 | -3,08% | 2 175 270 |
09-05-24 | 5,84 | +1,57% | 1 718 298 |
08-05-24 | 5,75 | -3,04% | 2 676 953 |
07-05-24 | 5,93 | +2,24% | 2 436 694 |
06-05-24 | 5,8 | -6,00% | 5 676 152 |
uitgestelde koers Nasdaq, 10 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,91% | 877 mln. | |
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |